High- and low-dose interferon alpha 2b in high risk melanoma: first analysis of intergroup trial E1690/S9111/C9190. - Kirkwood,J.M.; Ibrahim,J.G.; Sondak,V.K.; Richards,J.; Flaherty,L.E.; Ernstoff,M.S.; Smith,T.J.; Rao,U.; Steele,M.; Blum,R.H. (J Clin Oncol, 2000)